Dna X (SONM) Change in Account Payables (2018 - 2026)

Dna X has reported Change in Account Payables for 9 years, with the latest figure at -$2.7 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Account Payables rose 52.23% year-over-year to -$2.7 million; the trailing twelve-month figure through Mar 2026 stood at $12.4 million (up 51.33% YoY), and the FY2025 full-year result was $9.5 million, down 33.39% from the prior year.
• Change in Account Payables for Q1 2026 stood at -$2.7 million, down from $12.0 million in the prior quarter.
• The five-year high for Change in Account Payables was $13.8 million in Q4 2024, with the low at -$5.6 million in Q1 2025.
• Historically, Change in Account Payables has averaged $1.9 million across 5 years, with a median of $311000.0 in 2023.
• The largest YoY upside for Change in Account Payables was 3769.41% in 2025 against a maximum downside of 1128.52% in 2025.
• Dna X's Change in Account Payables stood at $8.7 million in 2022, then tumbled by 139.22% to -$3.4 million in 2023, then soared by 504.58% to $13.8 million in 2024, then declined by 13.2% to $12.0 million in 2025, then plunged by 122.16% to -$2.7 million in 2026.
• The last three Change in Account Payables figures came in at -$2.7 million (Q1 2026), $12.0 million (Q4 2025), and -$175000.0 (Q3 2025), per Business Quant data.